Skip to content
XPR – Lifestyle Demo
Author:
Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
June 8, 2026